To Guthion Stakeholders: 

Most of you have heard by now that Bayer CropScience has divested GUTHION 
(azinphos-methyl) to Makhteshim (MANA). BCS is providing the following 
information to answer many of the questions that may come to mind: 

1. MANA purchased Guthion in Europe several years ago. The recent 
divestiture includes North and South America; 
2. BCS is selling all inventory to MANA. There will be no co-marketing; 
3. Existing BCS-labeled product owned by distribution and retail channels 
of trade can still, and should be, sold by the channel to growers as 
before; 
4. All responsibilities for any new GUTHION/AZM will be the responsibility 
of MANA; 
5. BCS will no longer promote GUTHION in advertising or other forms of 
communication.

If other questions do come up, please ask. 

You know that it was only through your hard work and effective actions 
that GUTHION remained available. EPA had intended to cancel the product in 
July 1999. It is impressive that through your efforts the needed uses have 
been maintained. For example, the apple use has been extended with the 
opportunity for re-review in 2012.

Please contact me with any questions.

Dan DiGiacomandrea
Bayer CropScience
68 Chadwick Manor
Fairport, NY 14450
585-330-3263
Fax 585-425-8774
Email: [EMAIL PROTECTED] 
Website: http://www.bayercropscienceus.com/rep/~dan.digiacomandrea 

_______________________________________________________________________________________________

The information contained in this e-mail is for the exclusive use of the 
intended recipient(s) and may be confidential, proprietary, and/or legally 
privileged.  Inadvertent disclosure of this message does not constitute a 
waiver of any privilege.  If you receive this message in error, please do not 
directly or indirectly use, print, copy, forward, or disclose any part of this 
message.  Please also delete this e-mail and all copies and notify the sender.  
Thank you.

For alternate languages please go to http://bayerdisclaimer.bayerweb.com
_______________________________________________________________________________________________

Reply via email to